Glaukos
GKOS
#2552
Rank
โ‚น675.65 B
Marketcap
โ‚น11,504
Share price
-13.52%
Change (1 day)
40.62%
Change (1 year)

Revenue for Glaukos (GKOS)

Revenue in 2026 (TTM): โ‚น49.42 Billion

According to Glaukos's latest financial reports the company's current revenue (TTM ) is โ‚น52.75 Billion. In 2025 the company made a revenue of โ‚น45.55 Billion an increase over the revenue in the year 2024 that were of โ‚น32.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Glaukos from 2014 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น49.42 B8.5%
2025 โ‚น45.55 B38.47%
2024 โ‚น32.89 B25.57%
2023 โ‚น26.19 B11.93%
2022 โ‚น23.40 B6.96%
2021 โ‚น21.88 B33.01%
2020 โ‚น16.45 B-2.65%
2019 โ‚น16.89 B33.33%
2018 โ‚น12.67 B24.65%
2017 โ‚น10.16 B30.8%
2016 โ‚น7.77 B63.15%
2015 โ‚น4.76 B64.92%
2014 โ‚น2.88 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ICU Medical
ICUI
โ‚น213.48 B 304.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
โ‚น51.14 B-3.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
โ‚น157.19 B 197.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
โ‚น288.82 B 447.51%๐Ÿ‡บ๐Ÿ‡ธ USA